Literature DB >> 17679785

Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.

Melvin R Hayden1, Nazif Chowdhury, Guru Govindarajan, Poorna R Karuparthi, Javad Habibi, James R Sowers.   

Abstract

Myocardial cellular and extracellular matrix remodeling are important in the development of left ventricular hypertrophy and are essential for the adaptive and maladaptive changes associated with the cardiometabolic syndrome. This brief review of myocyte remodeling also presents preliminary observational findings regarding myocardial adaptive hypertrophy remodeling, including an increase in mitochondria and capillaries, convolutions and lengthening of intercalated discs, the addition of sarcomeres, thickened Z lines, and the novel presence of pericapillary fibrosis (in addition to perivascular arteriolar fibrosis). The 11-week-old TG(mREN-2)27 transgene rat model of tissue angiotensin II overexpression, which develops hypertension and insulin resistance, was chosen to examine both myocyte hypertrophy and extracellular matrix fibrosis. This review and the preliminary observational findings may provide the clinician and researcher a better understanding of remodeling changes in the myocardium and ultimately foster earlier recognition and therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17679785     DOI: 10.1111/j.1559-4564.2006.05626.x

Source DB:  PubMed          Journal:  J Cardiometab Syndr        ISSN: 1559-4564


  9 in total

1.  Maternal obesity induces fibrosis in fetal myocardium of sheep.

Authors:  Yan Huang; Xu Yan; Jun X Zhao; Mei J Zhu; Richard J McCormick; Stephen P Ford; Peter W Nathanielsz; Jun Ren; Min Du
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-09-28       Impact factor: 4.310

2.  High-salt diet during pregnancy and angiotensin-related cardiac changes.

Authors:  Yang Ding; Juanxiu Lv; Caiping Mao; Huiying Zhang; Aiqing Wang; Liyan Zhu; Hui Zhu; Zhice Xu
Journal:  J Hypertens       Date:  2010-06       Impact factor: 4.844

3.  Ultrastructure Study of Transgenic Ren2 Rat Aorta - Part 1: Endothelium and Intima.

Authors:  Melvin R Hayden; Javad Habibi; Tejaswini Joginpally; Poorna R Karuparthi; James R Sowers
Journal:  Cardiorenal Med       Date:  2012-01-27       Impact factor: 2.041

4.  Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.

Authors:  Melvin R Hayden; Kurt M Sowers; Lakshmi Pulakat; Tejaswini Joginpally; Bennett Krueger; Adam Whaley-Connell; James R Sowers
Journal:  Cardiorenal Med       Date:  2011-07-30       Impact factor: 2.041

Review 5.  The Mighty Mitochondria Are Unifying Organelles and Metabolic Hubs in Multiple Organs of Obesity, Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes: An Observational Ultrastructure Study.

Authors:  Melvin R Hayden
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 6.  Role of mitochondrial dysfunction in insulin resistance.

Authors:  Jeong-A Kim; Yongzhong Wei; James R Sowers
Journal:  Circ Res       Date:  2008-02-29       Impact factor: 17.367

7.  Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension.

Authors:  Chuan-Bao Li; Xiao-Xing Li; Yu-Guo Chen; Cheng Zhang; Ming-Xiang Zhang; Xue-Qiang Zhao; Ming-Xiu Hao; Xiao-Yang Hou; Mao-Lei Gong; Yu-Xia Zhao; Pei-Li Bu; Yun Zhang
Journal:  J Cell Mol Med       Date:  2009 Nov-Dec       Impact factor: 5.310

Review 8.  On the Road to Accurate Biomarkers for Cardiometabolic Diseases by Integrating Precision and Gender Medicine Approaches.

Authors:  Letizia Scola; Rosa Maria Giarratana; Salvatore Torre; Vincenzo Argano; Domenico Lio; Carmela Rita Balistreri
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

Review 9.  NLRP3 Inflammasome Biomarker-Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome.

Authors:  Andra-Iulia Suceveanu; Laura Mazilu; Niki Katsiki; Irinel Parepa; Felix Voinea; Anca Pantea-Stoian; Manfredi Rizzo; Florin Botea; Vlad Herlea; Dragos Serban; Adrian-Paul Suceveanu
Journal:  Metabolites       Date:  2020-11-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.